bpc-157 fda warning 2025 september issued 25 letters to telehealth companies for false and misleading claims about compounded GLP-1 products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of Peptides such as MOTS-c and

Its preservative prevents bacterial growth, allowing multiple withdrawals from the same vial

[DOI] [PubMed] [Google Scholar] 187.Zemba Cilic A., Zemba M., Cilic M., Balenovic I., Strbe S., Ilic S., Vukojevic J., Zoricic Z., Filipcic I., Kokot A., et al

Its potential is compelling, touching on everything from cellular regeneration to inflammatory response modulation

Storage requirements after reconstitution are critical

Unlike enrolling in a formal clinical trial (which has extensive consent forms explaining experimental status), patients at wellness clinics might assume if a doctor offered it, it must be safe or allowed. Such misunderstandings could lead to feelings of betrayal and litigation if things go wrong

Oral administration introduces complications